Sonuç Sayfası 12 için Sektör: Sağlık Hizmetleri Endüstri: Biyoteknoloji Borsası - Teklifler ve Fiyatlar
Fiyatlar, Piyasa Değerleri, PE ve EPS oranları ile tüm Hisse ve Net Varlıkların Listesi
Tüm ülkeler
- {{country.name}}
- Tüm ülkeler
- Amerika Birleşik Devletleri (1011)
- Avustralya (58)
- Avusturya (16)
- Belçika (7)
- Brezilya (16)
- Kanada (83)
- Çin (94)
- Danimarka (6)
- Finlandiya (4)
- Fransa (41)
- Almanya (737)
- Hong Kong (46)
- Hindistan (19)
- İrlanda (1)
- İsrail (19)
- İtalya (4)
- Japonya (37)
- Meksika (28)
- Hollanda (3)
- Yeni Zelanda (1)
- Norveç (14)
- Polonya (9)
- Rusya (2)
- Güney Kore (10)
- ispanya (4)
- İsveç (70)
- İsviçre (11)
- Tayvan (67)
- Tayland (2)
- Türkiye (1)
- Birleşik Krallık (69)
Tüm borsalar
- {{item.name}}
- Tüm borsalar
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Sağlık Hizmetleri (2608)
- {{item.name}}
- Tüm sektörler
- Sağlık Hizmetleri (2608)
Biyoteknoloji (2608)
- {{item.name}}
- Tüm Sektörler
- Biyoteknoloji (2608)
- İlaç Üreticileri-Genel (279)
- İlaç Üreticileri-Özel ve Genel (1702)
- Sağlık Hizmeti Planları (57)
- Tıbbi Bakım Tesisleri (554)
- Farmasötik Perakendeciler (155)
- Sağlık Bilgileri Hizmetleri (420)
- Tıbbi Cihazlar (913)
- Tıbbi Ekipmanlar ve Malzemeler (502)
- Teşhis ve Araştırma (427)
- Medikal Ürün Dağıtımı (138)
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK |
|---|
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Amarantus BioScience AMBS | $0.0001 — |
0
|
$63.04K — | $300.4K — | $0.0001 — | $0.0001 — | $63.04K — | 0 | -$0.01 — | |
| Statera Biopharma STAB | $0.0006999 — |
0
|
$49.99K — | $1.62K — | $0.0006999 — | $0.0006999 — | $49.99K — | 0 | -$2.36 — | |
| Adhera Therapeutics ATRX | $0.004499 — |
-25
|
$32.49K — | $12.55K — | $0.004499 — | $0.006 — | $32.49K — | 0 | -$1.17 — | |
| Itoco ITMC | $0.005 — |
0
|
$26K — | $30.16K — | $0.005 — | $0.005 — | $26K — | 0 | -$0.71 — | |
| Regenicin RGIN | $0.0001 — |
0
|
$15.35K — | $15K — | $0.0001 — | $0.0001 — | $15.35K — | 0 | -$0.01 — | |
| Evelo Biosciences EVLO | $0.0005 — |
-98.77
|
$9.49K — | $1.3K — | $0.0005 — | $0.05999 — | $9.49K — | 0 | -$15.64 — | |
| Omnimmune OMMH | $0.0001 — |
+49.25
|
$980 — | $169.07K — | $0.0001 — | $0.0001 — | $980 — | 0 | -$0.2 — | |
| U.S. Stem Cell USRM | $0 — |
0
|
$641 — | $450 — | $0 — | $0 — | $641 — | 0 | $0 — | |
| Rebus RBSH | $0 — |
-99
|
$32 — | $3.77K — | $0 — | $0.0001 — | $32 — | 0.000050 | $0.02 — | |
| NLS Pharmaceutics NLSPW | $0.02999 — |
-38.78
|
$0 — | $5.62K — | $0.02999 — | $0.02999 — | $0 — | 0 | $0 — | |
| Callitas Health MPHMF | $0.0001 — |
+9900
|
$0 — | $19.57K — | $0.0001 — | $0.0001 — | $0 — | 0 | $0 — | |
| Novo Nordisk A/S N1VO34.SA | $85.96 17.42 USD |
-0.94
|
$3.04T 616.27B USD | $567 114.92 USD | $85.96 17.42 USD | $86.75 17.58 USD | $3.04T 616.27B USD | 5.80 | $14.8 3 USD | |
| Novo Nordisk A/S NOVA.F | $122.5 133.91 USD |
-1.21
|
$546.85B 597.78B USD | $437 477.7 USD | $122.5 133.91 USD | $124.5 136.1 USD | $546.85B 597.78B USD | 45.88 | $2.67 2.92 USD | |
| Novo Nordisk A/S NVON.MX | $2,242 132.75 USD |
0
|
$5.17T 306.15B USD | $3.17K 187.7 USD | $2,242 132.75 USD | $2,242 132.75 USD | $5.17T 306.15B USD | 36.10 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $562.59 114.03 USD |
0
|
$582.4B 118.04B USD | $0 0 USD | $562.59 114.03 USD | $562.59 114.03 USD | $582.4B 118.04B USD | 28.57 | $19.69 3.99 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $410 448.19 USD |
+1.37
|
$106.47B 116.38B USD | $35 38.26 USD | $406.2 444.03 USD | $410 448.19 USD | $106.47B 116.38B USD | 28.87 | $14.2 15.52 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $409.9 448.08 USD |
+0.82
|
$105.89B 115.76B USD | $1 1.09 USD | $409.9 448.08 USD | $409.9 448.08 USD | $105.89B 115.76B USD | 28.88 | $14.19 15.51 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $407.2 445.12 USD |
+0.3
|
$105.34B 115.15B USD | $0 0 USD | $407.2 445.12 USD | $407.2 445.12 USD | $105.34B 115.15B USD | 28.73 | $14.17 15.49 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $83.2 16.86 USD |
0
|
$559.21B 113.34B USD | $0 0 USD | $83.2 16.86 USD | $83.2 16.86 USD | $559.21B 113.34B USD | 28.88 | $2.88 0.58 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $7,354.42 435.47 USD |
0
|
$1.9T 112.37B USD | $0 0 USD | $7,354.42 435.47 USD | $7,354.42 435.47 USD | $1.9T 112.37B USD | 28.81 | $255.2 15.11 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $916 1001.31 USD |
+0.2
|
$101.04B 110.46B USD | $0 0 USD | $916 1001.31 USD | $916 1001.31 USD | $101.04B 110.46B USD | 29.38 | $31.17 34.07 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $16,289.76 964.55 USD |
0
|
$1.81T 107.38B USD | $0 0 USD | $16,289.76 964.55 USD | $16,289.76 964.55 USD | $1.81T 107.38B USD | 29.06 | $560.37 33.18 USD | |
| CSL Limited CSJA.F | $84.5 92.37 USD |
+0.6
|
$82.89B 90.61B USD | $10 10.93 USD | $84.5 92.37 USD | $84.5 92.37 USD | $82.89B 90.61B USD | 36.11 | $2.34 2.56 USD | |
| CSL Limited CSJ.F | $169.68 185.48 USD |
+0.45
|
$82.77B 90.48B USD | $36 39.35 USD | $169.68 185.48 USD | $169.68 185.48 USD | $82.77B 90.48B USD | 36.25 | $4.68 5.12 USD | |
| CSL CMXHF | $181.79 — |
-2.07
|
$89.49B — | $900 — | $181.79 — | $182.05 — | $89.49B — | 35.71 | $5.09 — | |
| Moderna, Inc. 0QF.F | $136 148.67 USD |
+2.56
|
$52.12B 56.97B USD | $827 904.02 USD | $131.4 143.64 USD | $136 148.67 USD | $52.12B 56.97B USD | 0 | -$14.35 -15.6 USD | |
| Moderna, Inc. MRNA.VI | $131.64 143.9 USD |
+2.76
|
$51.57B 56.38B USD | $98 107.13 USD | $131.64 143.9 USD | $132.68 145.04 USD | $51.57B 56.38B USD | 0 | -$14.34 -15.6 USD | |
| Moderna, Inc. 0QF.MU | $131.82 144.1 USD |
+2.65
|
$50.79B 55.52B USD | $25 27.33 USD | $128.42 140.38 USD | $129.32 141.36 USD | $50.79B 55.52B USD | 0 | -$14.36 -15.7 USD | |
| Moderna, Inc. MRNA.MX | $2,369.99 140.33 USD |
0
|
$911.8B 53.99B USD | $367 21.73 USD | $2,369.99 140.33 USD | $2,369.99 140.33 USD | $911.8B 53.99B USD | 0 | -$258.3 -15.2 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $777,000 586.51 USD |
-0.26
|
$55.3T 41.74B USD | $41.15K 31.06 USD | $776,000 585.75 USD | $787,000 594.06 USD | $55.3T 41.74B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $6 6.56 USD | $227.2 248.36 USD | $227.2 248.36 USD | $27.27B 29.81B USD | 0 | -$7.12 -7.7 USD | |
| Celltrion, Inc. 068270.KS | $184,800 139.49 USD |
-0.75
|
$38.23T 28.85B USD | $310.56K 234.42 USD | $184,200 139.04 USD | $188,000 141.91 USD | $38.23T 28.85B USD | 0 | $0 0 USD | |
| UCB SA UNC0.F | $63 68.87 USD |
+2.44
|
$24.96B 27.29B USD | $4 4.37 USD | $63 68.87 USD | $63 68.87 USD | $24.96B 27.29B USD | 71.59 | $0.88 0.96 USD | |
| UCB SA UNC.F | $128.1 140.03 USD |
+1.34
|
$24.69B 26.99B USD | $40 43.73 USD | $128.1 140.03 USD | $128.1 140.03 USD | $24.69B 26.99B USD | 72.78 | $1.76 1.92 USD | |
| UCB SA UCB.VI | $121.3 132.6 USD |
0
|
$24.37B 26.64B USD | $0 0 USD | $121.3 132.6 USD | $121.3 132.6 USD | $24.37B 26.64B USD | 68.92 | $1.76 1.92 USD | |
| UCB SA UCBJF | $132 — |
+0.65
|
$26.14B — | $830 — | $132 — | $132.5 — | $26.14B — | 69.10 | $1.91 — | |
| BioNTech SE 0A3M.IL | $91.58 — |
+0.17
|
$25.19B — | $0 — | $91.58 — | $91.58 — | $25.19B — | 5.08 | $18 — | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $77 84.17 USD | $331 361.83 USD | $331 361.83 USD | $21.66B 23.68B USD | 68.12 | $4.86 5.31 USD | |
| BioNTech SE B1NT34.SA | $29.39 5.96 USD |
-0.14
|
$113.32B 22.97B USD | $4 0.81 USD | $28.84 5.85 USD | $29.39 5.96 USD | $113.32B 22.97B USD | 183.68 | $0.16 0.03 USD | |
| BioNTech SE 22UA.F | $84.45 92.32 USD |
+0.72
|
$20.58B 22.49B USD | $758 828.6 USD | $83.55 91.33 USD | $85.55 93.52 USD | $20.58B 22.49B USD | 179.68 | $0.47 0.51 USD | |
| BioNTech SE BNTX.VI | $84.65 92.53 USD |
+0.53
|
$20.54B 22.45B USD | $0 0 USD | $84.65 92.53 USD | $84.65 92.53 USD | $20.54B 22.45B USD | 180.10 | $0.47 0.51 USD | |
| argenx SE ARGNF | $373.5 — |
<0.01
|
$22.2B — | $1.01K — | $373.5 — | $373.5 — | $22.2B — | 0 | -$5.68 — | |
| argenx SE A1RG34.SA | $73.36 14.87 USD |
0
|
$108.69B 22.03B USD | $0 0 USD | $73.36 14.87 USD | $73.36 14.87 USD | $108.69B 22.03B USD | 0 | -$29 -5.8 USD | |
| argenx SE ARGX.VI | $329.2 359.86 USD |
-1.23
|
$19.56B 21.39B USD | $0 0 USD | $329.2 359.86 USD | $329.2 359.86 USD | $19.56B 21.39B USD | 0 | -$5.23 -5.7 USD | |
| argenx SE 1AE.F | $327.7 358.22 USD |
-1.89
|
$19.48B 21.29B USD | $2 2.19 USD | $327.7 358.22 USD | $327.7 358.22 USD | $19.48B 21.29B USD | 0 | -$5.24 -5.7 USD | |
| argenx SE 1AEA.F | $324 354.18 USD |
-1.22
|
$19.36B 21.16B USD | $10 10.93 USD | $324 354.18 USD | $324 354.18 USD | $19.36B 21.16B USD | 0 | -$5.22 -5.7 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $38.3 7.76 USD |
0
|
$96.89B 19.64B USD | $0 0 USD | $38.3 7.76 USD | $38.3 7.76 USD | $96.89B 19.64B USD | 0 | -$0.67 -0.1 USD | |
| Genmab A/S GNMSF | $298.55 — |
-1.34
|
$19.28B — | $697 — | $287.75 — | $298.55 — | $19.28B — | 24.69 | $12.09 — | |
| BeiGene, Ltd. 49BA.F | $154 168.34 USD |
-1.28
|
$17.47B 19.09B USD | $20 21.86 USD | $154 168.34 USD | $154 168.34 USD | $17.47B 19.09B USD | 0 | -$6.94 -7.5 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $136.8 149.54 USD |
-0.26
|
$17.38B 19B USD | $30 32.79 USD | $136.8 149.54 USD | $136.8 149.54 USD | $17.38B 19B USD | 0 | -$2.43 -2.6 USD | |
| Genmab A/S GMAB.VI | $268.5 293.51 USD |
-0.04
|
$17.33B 18.95B USD | $0 0 USD | $268.5 293.51 USD | $268.5 293.51 USD | $17.33B 18.95B USD | 24.14 | $11.12 12.16 USD | |
| BeiGene, Ltd. B1GN34.SA | $34.94 7.08 USD |
0
|
$92.48B 18.74B USD | $0 0 USD | $34.94 7.08 USD | $34.94 7.08 USD | $92.48B 18.74B USD | 0 | -$2.96 -0.5 USD | |
| BeiGene, Ltd. 49B.F | $11.9 13.01 USD |
+2.59
|
$17.11B 18.7B USD | $340 371.67 USD | $11.9 13.01 USD | $11.9 13.01 USD | $17.11B 18.7B USD | 0 | -$0.53 -0.5 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,557.87 92.24 USD |
0
|
$295.81B 17.52B USD | $0 0 USD | $1,557.87 92.24 USD | $1,557.87 92.24 USD | $295.81B 17.52B USD | 88.51 | $17.6 1.04 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $23 25.14 USD | $80.76 88.28 USD | $81.08 88.63 USD | $15.26B 16.68B USD | 115.74 | $0.7 0.77 USD | |
| Royalty Pharma plc RPD.MU | $25.27 27.62 USD |
-0.2
|
$14.92B 16.31B USD | $100 109.31 USD | $25.27 27.62 USD | $25.27 27.62 USD | $14.92B 16.31B USD | 15.40 | $1.64 1.79 USD | |
| Royalty Pharma plc RPD.F | $24.76 27.07 USD |
-0.99
|
$14.8B 16.18B USD | $5 5.47 USD | $24.76 27.07 USD | $25.01 27.34 USD | $14.8B 16.18B USD | 15.09 | $1.64 1.79 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $195.9 39.71 USD |
0
|
$74.98B 15.2B USD | $0 0 USD | $195.9 39.71 USD | $195.9 39.71 USD | $74.98B 15.2B USD | 72.55 | $2.7 0.55 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $71.04 77.66 USD |
+0.45
|
$13.58B 14.85B USD | $100 109.31 USD | $71.04 77.66 USD | $71.04 77.66 USD | $13.58B 14.85B USD | 72.48 | $0.98 1.07 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $70.5 77.07 USD |
0
|
$13.52B 14.78B USD | $0 0 USD | $70.5 77.07 USD | $70.96 77.57 USD | $13.52B 14.78B USD | 72.68 | $0.97 1.06 USD | |
| Bio-Techne Corporation T1CH34.SA | $14.2 2.88 USD |
0
|
$67.13B 13.61B USD | $0 0 USD | $14.2 2.88 USD | $14.2 2.88 USD | $67.13B 13.61B USD | 67.61 | $0.21 0.04 USD | |
| Incyte Corporation I1NC34.SA | $136.64 27.69 USD |
0
|
$65.9B 13.36B USD | $0 0 USD | $136.64 27.69 USD | $136.64 27.69 USD | $65.9B 13.36B USD | 16.20 | $8.43 1.71 USD | |
| Incyte Corporation INCY.MX | $986 58.38 USD |
0
|
$221.71B 13.13B USD | $0 0 USD | $986 58.38 USD | $986 58.38 USD | $221.71B 13.13B USD | 17.92 | $55.02 3.26 USD | |
| Incyte Corporation ICY.F | $52.74 57.65 USD |
+0.65
|
$11.96B 13.08B USD | $200 218.63 USD | $52.74 57.65 USD | $52.74 57.65 USD | $11.96B 13.08B USD | 17.34 | $3.04 3.32 USD | |
| Bio-Techne Corporation TE1.F | $75.5 82.53 USD |
-0.66
|
$11.92B 13.03B USD | $2 2.19 USD | $75.5 82.53 USD | $75.5 82.53 USD | $11.92B 13.03B USD | 65.65 | $1.15 1.26 USD | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $33.18 6.73 USD |
0
|
$62.73B 12.71B USD | $0 0 USD | $33.18 6.73 USD | $33.18 6.73 USD | $62.73B 12.71B USD | 301.63 | $0.11 0.02 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| United Therapeutics Corporation UTH.F | $252 275.47 USD |
+0.32
|
$11.28B 12.33B USD | $15 16.4 USD | $252 275.47 USD | $252 275.47 USD | $11.28B 12.33B USD | 12.96 | $19.44 21.25 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $118.35 129.37 USD |
-1.13
|
$11.19B 12.23B USD | $4 4.37 USD | $118.35 129.37 USD | $118.35 129.37 USD | $11.19B 12.23B USD | 295.87 | $0.4 0.44 USD | |
| Bio-Techne Corporation TECH.MX | $1,310.32 77.59 USD |
-2.54
|
$206.49B 12.23B USD | $0 0 USD | $0 0 USD | $0 0 USD | $206.49B 12.23B USD | 51.58 | $25.4 1.5 USD | |
| Roivant Sciences Ltd. 87S.F | $9.87 10.79 USD |
-0.86
|
$8.26B 9.03B USD | $1K 1.09K USD | $9.87 10.78 USD | $9.87 10.79 USD | $8.26B 9.03B USD | 2.03 | $4.85 5.3 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Vaxcyte, Inc. 5VA.MU | $68 74.33 USD |
-2.16
|
$7.4B 8.09B USD | $10 10.93 USD | $68 74.33 USD | $68 74.33 USD | $7.4B 8.09B USD | 0 | -$3.95 -4.3 USD | |
| Innovent Biologics IVBXF | $4.97 — |
-2.55
|
$8.06B — | $5.2K — | $4.97 — | $5.09 — | $8.06B — | 0 | -$0.09 — | |
| Vaxcyte, Inc. 5VA.F | $67.5 73.79 USD |
-2.88
|
$7.34B 8.03B USD | $4 4.37 USD | $67.5 73.79 USD | $67.5 73.79 USD | $7.34B 8.03B USD | 0 | -$3.95 -4.3 USD | |
| Innovent Biologics, Inc. 6IB.F | $4.48 4.9 USD |
0
|
$7.31B 8B USD | $100 109.31 USD | $4.48 4.9 USD | $4.6 5.03 USD | $7.31B 8B USD | 0 | -$0.08 -0.08 USD | |
| Legend Biotech Corporation 9LB.F | $39.2 42.85 USD |
+0.51
|
$7.25B 7.92B USD | $20 21.86 USD | $39.2 42.85 USD | $39.2 42.85 USD | $7.25B 7.92B USD | 0 | -$2.38 -2.6 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $900 53.29 USD |
0
|
$131.37B 7.78B USD | $0 0 USD | $900 53.29 USD | $900 53.29 USD | $131.37B 7.78B USD | 0 | -$42.65 -2.5 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $92 100.57 USD | $21.09 23.05 USD | $21.09 23.05 USD | $6.79B 7.42B USD | 23.17 | $0.91 0.99 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $1.6 1.74 USD |
+3.61
|
$6.7B 7.33B USD | $2K 2.19K USD | $1.54 1.69 USD | $1.6 1.74 USD | $6.7B 7.33B USD | 15.95 | $0.1 0.11 USD | |
| Viking Therapeutics, Inc. 1VT.F | $60.32 65.94 USD |
+0.2
|
$6.65B 7.27B USD | $168 183.65 USD | $58.24 63.66 USD | $60.9 66.57 USD | $6.65B 7.27B USD | 0 | -$0.85 -0.9 USD | |
| Ascendis Pharma A/S A1SN34.SA | $48.42 9.81 USD |
0
|
$35.83B 7.26B USD | $0 0 USD | $48.42 9.81 USD | $48.42 9.81 USD | $35.83B 7.26B USD | 0 | -$49.18 -9.9 USD | |
| Ascendis Pharma A/S A71.F | $113 123.52 USD |
+1.8
|
$6.58B 7.19B USD | $1K 1.09K USD | $113 123.52 USD | $113 123.52 USD | $6.58B 7.19B USD | 0 | -$8.87 -9.6 USD | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.34 0.37 USD |
-0.38
|
$6.52B 7.13B USD | $1.06K 1.15K USD | $0.34 0.37 USD | $0.34 0.37 USD | $6.52B 7.13B USD | 34.06 | $0.01 0.01 USD | |
| Sino Biopharmaceutical SBHMY | $7.2 — |
-2.83
|
$7.11B — | $1.04K — | $7.2 — | $7.2 — | $7.11B — | 24.82 | $0.29 — | |
| Sino Biopharmaceutical Limited SBMFF | $0.32 — |
-9.83
|
$7.11B — | $500 — | $0.32 — | $0.32 — | $7.11B — | 31.49 | $0.01 — | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $3 3.28 USD |
0
|
$6.47B 7.07B USD | $1.05K 1.14K USD | $3 3.28 USD | $3 3.28 USD | $6.47B 7.07B USD | 15.00 | $0.2 0.22 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $99.24 108.48 USD |
+0.59
|
$6.26B 6.84B USD | $5 5.47 USD | $97.8 106.91 USD | $99.24 108.48 USD | $6.26B 6.84B USD | 22.30 | $4.45 4.86 USD | |
| Revolution Medicines, Inc. 42Z.F | $36.4 39.79 USD |
-0.55
|
$6.01B 6.56B USD | $25 27.33 USD | $36.4 39.79 USD | $36.4 39.79 USD | $6.01B 6.56B USD | 0 | -$3.54 -3.8 USD | |
| Blueprint Medicines Corporation 2L9.F | $94.06 102.82 USD |
-0.84
|
$5.92B 6.48B USD | $50 54.66 USD | $94.06 102.82 USD | $94.06 102.82 USD | $5.92B 6.48B USD | 0 | -$4.44 -4.8 USD | |
| Cytokinetics, Incorporated KK3A.F | $55 60.12 USD |
0
|
$5.81B 6.35B USD | $200 218.63 USD | $55 60.12 USD | $55 60.12 USD | $5.81B 6.35B USD | 0 | -$4.97 -5.4 USD | |
| ALK-Abelló A/S AKBLF | $22.45 — |
+20.38
|
$6.26B — | $1 — | $22.45 — | $22.45 — | $6.26B — | 59.07 | $0.38 — | |
| Exelixis, Inc. EX9.F | $19.17 20.96 USD |
-0.16
|
$5.63B 6.15B USD | $505 552.03 USD | $19.17 20.96 USD | $19.17 20.96 USD | $5.63B 6.15B USD | 31.94 | $0.6 0.66 USD | |
|
Favori hisse senedi yok.
Henüz favori bir hisse senediniz yok, lütfen burada görmek için favorilere ekleyin |
||||||||||